Citation: | LÜ Haokun, YANG Tenghui, WU Qici, et al. Exploring the Effect of Glucosamine Hydrochloride on Liver Cancer Using Zebrafish Liver Cancer Model[J]. Science and Technology of Food Industry, 2024, 45(20): 332−340. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2023110259. |
[1] |
RYMGAY H, ARNOLD M, FERLAY J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040[J]. Hepatol,2022,6:1598−1606.
|
[2] |
ALLEMMANI C, MATSUDA T, CARLO V D, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3):Analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]. Lancet,2018,391(10125):1023−1075. doi: 10.1016/S0140-6736(17)33326-3
|
[3] |
PASCALE R M, SIMILE M, PEITTA G, et al. Experimental models to define the genetic predisposition to liver cancer[J]. Cancers (Basel),2019,10:1450.
|
[4] |
YE Z, GAO X, ZHAO B, et al. Diwu yanggan capsule inhibits the occurrence and development of liver cancer in the Solt-Farber rat model by regulating the Ras/Raf/Mek/Erk signaling pathway[J]. Am J Transl Res,2018,11:3797−3805.
|
[5] |
明成, 武云. RAS/RAF/丝裂原活化蛋白激酶/细胞外信号调节激酶信号通路在胃癌中的研究进展[J]. 癌症进展,2023,21(3):249−252,272. [MING C, WU Y. Research progress on RAS/RAF/mitogen activated protein kinase/extracellular signal-regulated kinase signaling pathway in gastric cancer[J]. Cancer Progress,2023,21(3):249−252,272.]
MING C, WU Y. Research progress on RAS/RAF/mitogen activated protein kinase/extracellular signal-regulated kinase signaling pathway in gastric cancer[J]. Cancer Progress, 2023, 21(3): 249−252,272.
|
[6] |
杨军, 陈明, 清董坚. VEGF/VEGFR2信号转导通路在抗肿瘤血管生成中的作用[J]. 世界华人消化杂志,2007,15(34):6. [YANG J, CHRN M, QING D J. The role of VEGF/VEGFR2 signaling pathway in anti-tumor angiogenesis[J]. World Chinese Journal of Digestion,2007,15(34):6.] doi: 10.3969/j.issn.1009-3079.2007.34.010
YANG J, CHRN M, QING D J. The role of VEGF/VEGFR2 signaling pathway in anti-tumor angiogenesis[J]. World Chinese Journal of Digestion, 2007, 15(34): 6. doi: 10.3969/j.issn.1009-3079.2007.34.010
|
[7] |
OLSSON A K, DIMERG A, KREGUER J, et al. VEGF receptor signalling in control of vascular function[J]. Nature Reviews Molecular Cell Biology,2006,7(5):359−371. doi: 10.1038/nrm1911
|
[8] |
INOUE T, KINOSHITA H, KOMAI Y, et al. Two cases of gastrointestinal perforation after radiotherapy in patients receiving tyrosine kinase inhibitor for advanced renal cell carcinoma[J]. World J Surg Oncol, 2012,10(1):167.
|
[9] |
DURAN JM, MAKAREWICH CA, TRAPPANESE D, et al. Sorafenib cardiotoxicity increases mortality after myocardial infarction[J]. Circ Res,2014,11:1700−1712.
|
[10] |
陈忻, 袁毅桦, 符庆强等. 氨基葡萄糖盐酸盐的制备[J]. 福建水产, 2000(2):15−20. [CHEN X, YUAN Y H, FU Q Q, et al. Preparation of glucosamine hydrochloride [J] Fujian Fisheries, 2000(2):15−20.]
CHEN X, YUAN Y H, FU Q Q, et al. Preparation of glucosamine hydrochloride [J] Fujian Fisheries, 2000(2): 15−20.
|
[11] |
邱贵兴, 翁习生, 张克等. 盐酸/硫酸氨基葡萄糖治疗骨关节炎的平行对照临床研究[J]. 中华医学杂志,2005(43):49−52. [QIU G X, WENG X S, ZHANG K, et al. A parallel controlled clinical study on the treatment of osteoarthritis with hydrochloric acid/glucosamine sulfate[J]. Chinese Journal of Medicine,2005(43):49−52.]
QIU G X, WENG X S, ZHANG K, et al. A parallel controlled clinical study on the treatment of osteoarthritis with hydrochloric acid/glucosamine sulfate[J]. Chinese Journal of Medicine, 2005(43): 49−52.
|
[12] |
张文娟, 许璟瑾, 姚丽云, 等. 氨基葡萄糖盐酸盐及其衍生物对斑马鱼骨骼损伤修复的比较研究[J]. 中国比较医学杂志,2018,28(12):9−13,31. [ZHANG W J, XU J J, YAO L Y, et al. Comparative study of glucosamine hydrochloride and its derivatives on bone injury repair in zebrafish[J]. Chinese Journal of Comparative Medicine,2018,28(12):9−13,31.] doi: 10.3969/j.issn.1671-7856.2018.12.002
ZHANG W J, XU J J, YAO L Y, et al. Comparative study of glucosamine hydrochloride and its derivatives on bone injury repair in zebrafish[J]. Chinese Journal of Comparative Medicine, 2018, 28(12): 9−13,31. doi: 10.3969/j.issn.1671-7856.2018.12.002
|
[13] |
迟海林, 李菲菲, 张李伟, 等. 氨基葡萄糖类物质在保健食品中的应用及研究进展[J]. 食品工业科技,2023,44(8):437−445. [CHI H L, LI F F, ZHANG L W, et al. Application and research progress of glucosamine compounds in health food[J]. Food Industry Technology,2023,44(8):437−445.]
CHI H L, LI F F, ZHANG L W, et al. Application and research progress of glucosamine compounds in health food[J]. Food Industry Technology, 2023, 44(8): 437−445.
|
[14] |
李运曼, 唐明月, 夏雯, 等. D-氨基葡萄糖盐酸盐的抗肿瘤作用[J]. 中国天然药物, 2003(4):45−47. [LI Y M, TANG M Y, XIA W, et al. The anti-tumor effect of D-glucosamine hydrochloride [J] Chinese Natural Medicine, 2003(4):45−47.]
LI Y M, TANG M Y, XIA W, et al. The anti-tumor effect of D-glucosamine hydrochloride [J] Chinese Natural Medicine, 2003(4): 45−47.
|
[15] |
ZHANG L, LIU WS, HAN BQ, et al. Antitumor activities of D-glucosamine and its derivatives[J]. J Zhejiang Univ Sci B,2006,8:608−614.
|
[16] |
MOU H, OZATA DM, SMITH JL, et al. Crispr-sonic:Targeted somatic oncogene knock-in enables rapid in vivo cancer modeling[J]. Genome Med,2019,11(1):21. doi: 10.1186/s13073-019-0627-9
|
[17] |
LU JW, HO YJ, YANG YJ, et al. Zebrafish as a disease model for studying human hepatocellular carcinoma[J]. World J Gastroenterol,2015,42:12042−12058.
|
[18] |
CHEW TW, LIU XJ, LIU L, et al. Crosstalk of ras and rho:activation of rhoa abates kras-induced liver tumorigenesis in transgenic zebrafish models.[J]. Oncogene,2014,21:2717−2727.
|
[19] |
陈胜. 基于kras转基因斑马鱼的促肝癌性环境污染物高通量筛选及作用机制研究[D]. 武汉:华中农业大学, 2022. [CHEN S. High throughput screening and mechanism of action of liver cancer promoting environmental pollutants based on Kras transgenic zebrafish [D] Wuhan:Huazhong Agricultural University, 2022.]
CHEN S. High throughput screening and mechanism of action of liver cancer promoting environmental pollutants based on Kras transgenic zebrafish [D] Wuhan: Huazhong Agricultural University, 2022.
|
[20] |
PENG W, ZHANG W, WU Q, et al. Agaricus bisporus-derived glucosamine hydrochloride facilitates skeletal injury repair through bmp signaling in zebrafish osteoporosis model[J]. J Nat Prod,1970,4:1294−1305.
|
[21] |
LI T, FU J, ZENG Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells[J]. Nucleic Acids Res,2020,W1:W509−W514.
|
[22] |
KIM H, RONAI Z A. PRMT5 function and targeting in cancer[J]. Cell Stress,2020,4(8):199−215. doi: 10.15698/cst2020.08.228
|
[23] |
张尤历, 葛璐, 陆瑛, 等. PRMT5对肝癌细胞增殖及凋亡的影响[J]. 中国细胞生物学学报,2015,37(12):1639−1645. [ZHANG Y L, GE L, LU Y, et al. Effect of PRMT5 on proliferation and apoptosis of hepatocellular carcinoma cells[J]. Chinese Journal of Cell Biolology,2015,37(12):1639−1645.]
ZHANG Y L, GE L, LU Y, et al. Effect of PRMT5 on proliferation and apoptosis of hepatocellular carcinoma cells[J]. Chinese Journal of Cell Biolology, 2015, 37(12): 1639−1645.
|
[24] |
DING Y, CHEN B, WANG S, et al. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients[J]. International Journal of Cancer,2009,124(3):653−658. doi: 10.1002/ijc.23954
|
[25] |
HUANG J, YE X, GUAN J, et al. Tiam1 is associated with hepatocellular carcinoma metastasis[J]. Int J Cancer,2013,1:90−100.
|
[26] |
KWAN SY, SHEEL A, SONG CQ, et al. Depletion of TRRAP Induces p53-Independent senescence in liver cancer by down-regulating mitotic genes[J]. Hepatology,2020,1:275−290.
|
[27] |
WEI X, CAI S, BOOHAKER RJ, et al. KAT5 promotes invasion and metastasis through C-MYC stabilization in ATC[J]. Endocr Relat Cancer,2019,1:141−151.
|
[28] |
LIU Z L, CHEN H H, ZHENG L L, et al. Angiogenic signaling pathways and anti-angiogenic therapy for cancer[J]. Signal Transduct Target Ther,1970,1:198.
|
[29] |
PAWLAK JB, BLOBE GC. TGF-β superfamily co-receptors in cancer[J]. Dev Dyn,2022,1:137−163.
|
[30] |
LIU A, YU C, QIU C, WU Q, HUANG C, LI X, et al. PRMT5 methylating SMAD4 activates TGF-β signaling and promotes colorectal cancer metastasis[J]. Oncogene,2023,19:1572−1584.
|
[31] |
梁宗英, 杨阳, 郑竞雄, 等. 乙酰基转移酶抑制剂对食管癌细胞KAT5、Survivin乙酰化水平及细胞增殖和迁移的影响[J]. 重庆医学,2023,52(2):167−171. [LIANG Z Y, YANG Y, ZHENG J X, et al. The effect of acetyltransferase inhibitors on KAT5, Survivin acetylation levels, cell proliferation and migration in esophageal cancer cells[J]. Chongqing Medical Journal,2023,52(2):167−171.] doi: 10.3969/j.issn.1671-8348.2023.02.002
LIANG Z Y, YANG Y, ZHENG J X, et al. The effect of acetyltransferase inhibitors on KAT5, Survivin acetylation levels, cell proliferation and migration in esophageal cancer cells[J]. Chongqing Medical Journal, 2023, 52(2): 167−171. doi: 10.3969/j.issn.1671-8348.2023.02.002
|
[32] |
ZHANG X, LIU L, DENG X, et al. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells[J]. Oncogene,2019,5:699−715.
|
[33] |
SUN Jiarui, WU Qici, WEI Yuxin, et al. Agaricus bisporus-derived glucosamine hydrochloride regulates VEGF through BMP signaling to promote zebrafish vascular development and impairment repair[J]. Life,2023,13(12):2330. doi: 10.3390/life13122330
|
1. |
于心雨,胡云霄,魏琳,王舒悦,李珊珊,胡福良. 2023年国内外蜂王浆研究概况. 中国蜂业. 2024(03): 38-49 .
![]() |